Suitable for high-density and rapid proliferation of MDCK cells, under serum-free and protein-free conditions. Also suitable
for MDCK adherent cells’ rapid suspension adaptation. Supports efficient production of the influenza virus. In 2016, SF003
was applied in the first serum-free, full-suspension cell-based avian influenza vaccine large scale production project in the
world (6000L).